Plain-English translation of NCT06858345 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing a new approach to treating high blood pressure during pregnancy. Instead of giving all patients the same medication, doctors will first measure how each woman's heart and blood vessels are working, then choose blood pressure medication that matches her specific needs. The goal is to see if this personalized approach works better and keeps both mother and baby safer.
High blood pressure during pregnancy is serious and can harm both mother and baby, but not all patients respond the same way to standard treatments. This study exists to find out whether tailoring the medication to each woman's unique heart function can prevent complications and lead to better outcomes.
You likely qualify if…
You likely don't qualify if…
You would receive specialized heart function testing (such as ultrasound or monitoring) to understand your specific cardiovascular pattern. Based on those results, your doctor would prescribe blood pressure medication matched to your individual needs. You would be followed throughout the rest of your pregnancy to track how long you stay pregnant and how well the personalized treatment works for you and your baby.
AI-generated summary from trial data · Jul 7, 2026 · Not medical advice
Spain
Enrollment target
~50 participants
Started
January 2025
Primary completion
January 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Sex
Female only
Last updated on clinicaltrials.gov in March 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Catalina de Paco Matallana, MD
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.